Psoriasis Association - #Psoriasis treatment updates… 1️⃣ Bettamousse Foam – There is currently a short-term supply issue with the topical corticosteroid scalp treatment, Bettamousse Foam. New stocks are expected towards the end
![Efficacy and Safety of Calcipotriene/Betamethasone Dipropionate Foam in the Treatment of Psoriasis in Skin of Color - JDDonline - Journal of Drugs in Dermatology Efficacy and Safety of Calcipotriene/Betamethasone Dipropionate Foam in the Treatment of Psoriasis in Skin of Color - JDDonline - Journal of Drugs in Dermatology](https://s3.amazonaws.com/dl.jddonline.com/articleimages/M6910_ALEXIS/Efficacy-and-Safety-of-Calcipotriene-Betamethasone-Dipropionate-Foam-in-the-Treatment-of-Psoriasis-in-Skin-of-Color-FIGURE1.png)
Efficacy and Safety of Calcipotriene/Betamethasone Dipropionate Foam in the Treatment of Psoriasis in Skin of Color - JDDonline - Journal of Drugs in Dermatology
![The Impact and Treatment of Psoriasis in Manitoba Dermatology Clinics: The Case for Calcipotriol-Betamethasone Dipropionate Foam Formulation The Impact and Treatment of Psoriasis in Manitoba Dermatology Clinics: The Case for Calcipotriol-Betamethasone Dipropionate Foam Formulation](https://www.skintherapyletter.com/wp-content/uploads/2012/11/psoriasis-calcipotriol-betamethasone-dipropionate.jpg)
The Impact and Treatment of Psoriasis in Manitoba Dermatology Clinics: The Case for Calcipotriol-Betamethasone Dipropionate Foam Formulation
![The Impact and Treatment of Psoriasis in Manitoba Dermatology Clinics: The Case for Calcipotriol-Betamethasone Dipropionate Foam Formulation The Impact and Treatment of Psoriasis in Manitoba Dermatology Clinics: The Case for Calcipotriol-Betamethasone Dipropionate Foam Formulation](https://www.skintherapyletter.com/wp-content/uploads/2020/11/15_1-fig1.jpg)
The Impact and Treatment of Psoriasis in Manitoba Dermatology Clinics: The Case for Calcipotriol-Betamethasone Dipropionate Foam Formulation
![Pretreatment with an Aerosol Foam Containing Calcipotriene and Betamethasone Strongly Improves the Efficacy of Narrow-Band UVB Phototherapy | Dermatology and Therapy Pretreatment with an Aerosol Foam Containing Calcipotriene and Betamethasone Strongly Improves the Efficacy of Narrow-Band UVB Phototherapy | Dermatology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-022-00792-0/MediaObjects/13555_2022_792_Fig2_HTML.jpg)
Pretreatment with an Aerosol Foam Containing Calcipotriene and Betamethasone Strongly Improves the Efficacy of Narrow-Band UVB Phototherapy | Dermatology and Therapy
![The Impact and Treatment of Psoriasis in Manitoba Dermatology Clinics: The Case for Calcipotriol-Betamethasone Dipropionate Foam Formulation The Impact and Treatment of Psoriasis in Manitoba Dermatology Clinics: The Case for Calcipotriol-Betamethasone Dipropionate Foam Formulation](https://www.skintherapyletter.com/wp-content/uploads/2020/11/15_1-fig2.jpg)
The Impact and Treatment of Psoriasis in Manitoba Dermatology Clinics: The Case for Calcipotriol-Betamethasone Dipropionate Foam Formulation
![Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial) - ScienceDirect Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962220326256-gr1.jpg)
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial) - ScienceDirect
![A) Moderate-to-severe psoriasis in a 56-year-old male before treatment... | Download Scientific Diagram A) Moderate-to-severe psoriasis in a 56-year-old male before treatment... | Download Scientific Diagram](https://www.researchgate.net/publication/328151941/figure/fig5/AS:679622614208518@1539046066694/A-Moderate-to-severe-psoriasis-in-a-56-year-old-male-before-treatment-with-Cal-BD_Q320.jpg)